SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma

Pol Arch Intern Med. 2022 Aug 22;132(7-8):16266. doi: 10.20452/pamw.16266. Epub 2022 May 25.

Authors

Michał Kurlapski¹, Grzegorz Romanowicz², Michał Taszner¹, Jan M Zaucha³

Affiliations

¹ Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland
² Department of Nuclear Medicine, Medical University of Gdansk, Gdańsk, Poland
³ Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland. jzaucha@gumed.edu.pl

PMID: 35620893
DOI: 10.20452/pamw.16266

No abstract available

MeSH terms

COVID-19*
Hodgkin Disease* / drug therapy
Humans
SARS-CoV-2